Syndax Pharmaceuticals (SNDX) Q3 2025 Earnings

4AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.25
-1.11
-0.97
-0.83

Details

Expected EPS
-1.016219
Actual EPS
-0.83
Surprise EPS
0.19
Surprise Percent
+18.32%

Description

Syndax Pharmaceuticals (SNDX) has reported earnings of -0.83 per share for Q3 2025.

0 Comments

Share your thoughts